B dot Medical Inc. is pleased to announce a strategic collaboration agreement with RaySearch Laboratories AB (publ), a renowned provider of innovative software solutions for radiation therapy, aimed at advancing the field of proton therapy by development and validation of integrations between B dot Medical’s ultra-compact proton therapy system with non-rotating gantry and RaySearch’s treatment planning system and oncology information system.
RaySearch is a global provider of a radiation treatment planning system for more than 100 hospitals worldwide. Now the company takes a step further by developing advanced software solutions specifically designed to optimize proton therapy treatment planning for B dot Medical.
B dot Medical is dedicated to the development of an ultra-compact proton therapy system with a non-rotating gantry, which is strongly focused on achieving exceptional irradiation performance, including cutting-edge features such as high-speed scanning and respiratory-gated irradiation. At the core of their mission, “PROTON for everyone,” lies a steadfast commitment to providing high-quality proton therapy that enhances the quality of life for patients worldwide.
By leveraging RaySearch’s extensive global network and the groundbreaking proton therapy systems developed by B dot Medical, the partnership seeks to enhance the market position of each company’s respective system.
The collaboration aims at expanding the accessibility and availability of proton therapy technology to a wide range of healthcare facilities and regions worldwide. Ultimately, the goal is to benefit patients by making proton therapy more accessible in various hospitals.
Johan Löf, founder and CEO, RaySearch, says: “We are thrilled to join forces with B dot Medical in this groundbreaking collaboration. By combining our respective expertise, we can drive innovation and contribute to the advancement of proton therapy technology. Together, we are committed to improving cancer treatment outcomes and making proton therapy more accessible to patients globally.”
Takuji Furukawa, President and CEO, B dot Medical, says: “This collaboration represents a significant step forward in our mission, “PROTON for everyone." By partnering with RaySearch, we can further optimize the capabilities of our systems, bringing innovative solutions to the field of radiation oncology. We are excited about the impact this collaboration will have on patient care and will accelerate our business to expand the market for radiotherapy and propose optimal solutions to hospitals.”
About Proton Therapy
In proton therapy, the proton beam is directed at the precise depth of the tumor, causing little damage to the surrounding normal tissues. Proton therapy is expected to improve the quality of life for patients by enabling them to receive cancer treatment without significantly changing their daily lives.
However, proton therapy is currently available only to a limited number of patients and is not as common as the conventional radiation (photon) therapy. The reason for this is the high cost of construction and the space needed for installation in a hospital campus. Therefore, there are only 111 proton therapy facilities in operation around the world (as of 2020), very few compared to conventional radiation therapy.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation® treatment planning system (TPS) and the oncology information system (OIS) RayCare®. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About B dot Medical Inc.
B dot Medical is a startup company originating from the National Institute of Radiological Sciences (NIRS). The company has developed an ultra-compact proton therapy system, which is far more compact than the conventional ones, reducing to a size comparable to LINAC systems. The new development is expected to contribute to a significant increase in the number of proton therapy facilities by promoting its construction in urban areas where it has been difficult to do so until now, or in hospitals that had previously declined to consider it due to the cost.
